News | October 07, 2023
Amgen completes acquisition of Horizon Therapeutics
Advances Amgen's mission to serve patients with rare disease medicines
Advances Amgen's mission to serve patients with rare disease medicines
The Main campaign started from October 2
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
New Board of Directors and management team at Suven Pharma also appointed
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
Subscribe To Our Newsletter & Stay Updated
